Business Wire - 26 Mar 2024
CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity ...
Frontiers - 27 Jun 2024
Pancreatic Polypeptide but Not Other Members of the Neuropeptide Y Family Shows a Moderate Association With Perceived Anxiety in Obese Men ...
Nature.com - 27 Oct 2021
The effect of fatty diacid acylation of human PYY3-36 on Y2 receptor potency and half-life in minipigs | Scientific Reports ...
Nature.com - 12 Jun 2023
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss | Scientific Reports ...